NBP

Novabridge Biosciences Stock Analysis

AI Rating

Neutral
  • Quality2/10
  • Growth↓ 2/10
  • Value↑ 5/10
Novabridge Biosciences sales and earnings growth
NBP Growth
Fair
  • Revenue Y/Y↓ -100.00%
  • EPS Y/Y↑ 69.05%
  • FCF Y/Y↓ 0.00%
Novabridge Biosciences gross and profit margin trends
NBP Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ 0.00%
Novabridge Biosciences net debt vs free cash flow
NBP Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Novabridge Biosciences stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗